Brief: Solid Biosciences Outlines Key Priorities For Advancing Diversified Neuromuscular And Cardiac Development Pipeline
15/01/2025 21:08
Jan 15 (Reuters) - Solid Biosciences SLDB.O :
* SOLID BIOSCIENCES OUTLINES KEY PRIORITIES FOR ADVANCING
DIVERSIFIED NEUROMUSCULAR AND CARDIAC DEVELOPMENT PIPELINE AND
ESTABLISHING LEADERSHIP IN PRECISION GENETIC MEDICINES
* SOLID BIOSCIENCES INC - CASH AND INVESTMENTS EXPECTED TO
FUND
KEY STRATEGIC PRIORITIES INTO 2026
Source text: ID:nGNX4Vx72f
Further company coverage: SLDB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solid Biosciences
See all newsSolid Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Solid Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Solid Biosciences Q2 net loss widens on higher R&D costs
Marketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs